
Nerve health formulation launches in US to support chemotherapy patients
Novilora has launched in the US, bringing a science-based approach to supporting nerve health for people living through and beyond cancer treatment. Formulated by Italian internist and oncologist Dr Raffaele Migliaccio and sold in Europe as OnLife, Novilora combines palmitoylethanolamide (PEA) with a defined profile of fatty… Read More













